Medical Device News Magazine

Insulet Corporation

Insulet Announces FDA Clearance of its Omnipod® 5 Automated Insulin Delivery System

Omnipod 5 is the first tubeless automated insulin delivery (AID) system that integrates with the Dexcom G6 Continuous Glucose Monitoring (CGM) System and a compatible smartphone to automatically adjust insulin and help protect against highs and lows.

Insulet to Present New Clinical Data for Preschool Children and Adults using the Omnipod® 5 System

Insulet will present new clinical outcomes data for preschool children with type 1 diabetes using the Omnipod 5 Automated Insulin Delivery System (Omnipod 5).

Insulet Presents Omnipod Virtual Care Experience and Pre-Pivotal Study Results at the American Diabetes Association 80th Scientific Sessions

Omnipod 5 Automated Glucose Control System, Powered by Horizon™ (Omnipod 5), formerly known as the Omnipod Horizon System, is the first tubeless smartphone-controlled automated insulin delivery system for people living with diabetes.

Insulet Resumes Pivotal Study of its Next-Generation Product – Omnipod, Powered by Horizon™

Insulet expects to commercialize Omnipod, Powered by Horizon, in the U.S. in the first half of 2021, pending clearance by the FDA.
- Advertisement -spot_img

Latest News

Oblemic: A Comprehensive Review & Latest Research

Oblemic Reviews suggest that by integrating this supplement with healthy lifestyle choices, individuals may see significant improvements in their health. Unlike injectable treatments such as Ozempic and Wegovy, Oblemic is designed to provide similar benefits without the associated side effects.
- Advertisement -spot_img